Abiopharma

Clinical trial NCT07549490: start date: 2026-08-12 → 2026-08-13.

Clinical trial NCT06918925 updates: 1. start date: 2025-04-14 → 2025-05-14 2. completion date: 2026-06-30 → 2026-09-30 3. primary completion date: 2026-04-30 → 2026-05-30

Clinical trial NCT06290128 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-11-20 → 2027-10-31 3. primary completion date: 2027-05-17 → 2026-06-10 4. enrollment: 140 → 109 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07186595 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-01 → 2026-07-08 3. primary completion date: 2026-08-01 → 2026-07-08

Clinical trial NCT05624268 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. start date: 2023-01-19 → 2023-01-24 3. completion date: 2026-04-01 → 2026-04-15 4. enrollment: 255 → 258 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06053606 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-12-31 → 2027-03-31 3. primary completion date: 2026-12-31 → 2027-03-31

Clinical trial NCT03406611 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2026-12-01 → 2027-07-01 3. primary completion date: 2026-06-01 → 2027-07-01 4. enrollment: 32 → 39 participants

Clinical trial NCT07668752 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-15 → 2026-07-27

Clinical trial NCT05246033 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-03-01 → 2024-04-23

Clinical trial NCT07466745 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-30 → 2026-07-27